Childhood and adolescent large-cell lymphoma (LCL): A review of the Children's Cancer Group experience

American Journal of Hematology

Volumn 72, Issue 1, 2003, Pages 53-63

  Cairo, Mitchell S ^a,k   Sposto, Richard ^b   Hoover Regan, Margo ^c   Meadows, Anna T ^d   Anderson, James R ^e   Siegel, Stuart E ^f   Kadin, Marshall E ^g   Kjeldsberg, Carl R ^h   Wilson, John F ^h   Perkins, Sherrie L ^h   Lones, Mark A ⁱ   Morris, Erin ^a   Finlay, Jonathan L ^j  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c INDIANA UNIVERSITY   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

ⁱ ST JOSEPH HOSPITAL   (United States)

^j NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k CHILDREN S ONCOLOGY GROUP   (United States)

more..

Author keywords

Adolescents; Anaplastic; B cell; Children; Disseminated; Large cell lymphoma; Localized

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADOLESCENT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CENTRAL NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; L-LACTATE DEHYDROGENASE; LIFE TABLES; LYMPHOMA, LARGE-CELL; MALE; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 0037220449     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10262     Document Type: Article

References (39)

1. Smith SD, Rubin CM, Horvath A, Nachman J. Non-Hodgkin's lymphoma in children. Semin Oncol 1990;17(1):113-119.
2. Young JL Jr, Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 1986;58(2 Suppl):598-602.
3. Bleyer WA. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990;40(6):355-367.
4. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996;334(19):1238-1248.
5. Wilson JF, Jenkin RD, Anderson JR, Chilcote RR, Coccia P, Exelby PR, Kersey J, Kjeldsberg CR, Kushner J, Meadows A, Sheehan WW, Siegel S, Sposto R, Leikin S. Hammond D. Studies on the pathology of non-Hodgkin's lymphoma of childhood. I. The role of routine histopathology as a prognostic factor. A report from the Children's Cancer Study Group. Cancer 1984;53(8):1695-1704.
6. Kjeldsberg CR, Wilson JF, Berard CW. Non-Hodgkin's lymphoma in children. Hum Pathol 1983;14(7):612-627.
7. Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin's lymphomas of childhood: An analysis of the histology, staging, and response to treatment of 338 cases at a single institution [see comments]. J Clin Oncol 1989;7(2):186-193.
8. Meadows AT, Sposto R, Jenkin RD, Kersey JH. Chilcote RR, Siegel SE, Coccia PF, Rosenstock J, Pringle KC, Stolar CJ, Kadin ME, Hammond GD. Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: A report from the Children's Cancer Study Group. J Clin Oncol 1989;7(1):92-99.
9. Link MP, Shuster JJ, Donaldson SS, Berard CW, Murphy SB. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma [see comments]. N Engl J Med 1997;337(18):1259-1266.
10. Cairo MS, Perkins SL. Non-Hodgkin's lymphoma in children. In: Bast RC Jr, Kufe DW, Pollock RE, Weichselbau RR, Holland JF, Frei E III, editors. Cancer Medicine. London: B.C. Decker Inc; 2000. Vol E5, p 2162-2167.
11. Perkins SL. Work-up and diagnosis of pediatric non-Hodgkin's lymphomas. Pediatr Dev Pathol 2000;3(4):374-390.
12. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group [see comments]. Blood 1994;84(5):1361-1392.
13. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Airlie House, VA, November 1997. Hematol J 2000;1(1):53-66.
14. Foss HD, Anagnostopoulos I, Araujo I, Assaf C, Demel G, Kummer JA, Hummel M, Stein H. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996;88(10):4005-4011.
15. Brugieres L, Deley MC, Pacquement H, Meguerian-Bedoyan Z, Terrier-Lacombe MJ, Robert A, Pondarre C, Leverger G, Devalck C, Rodary C, Delsol G, Hartmann O. CD30(+) anaplastic large-cell lymphoma in children: Analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 1998;92(10):3591-3598.
16. + (anaplastic) large-cell lymphoma: Maturation of a clinicopathologic entity with prospects of effective therapy [editorial]. J Clin Oncol 1994;12(5):884-887.
17. Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmermann M, Yakisan E, Dopfer R, Bucsky P, Mann G, Gadner H. Successful treatment strategy for Ki-I anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Münster group studies. J Clin Oncol 1994;12(5):899-908.
18. + large-cell non-Hodgkin's lymphoma. J Clin Oncol 1994;12(5):895-898.
19. Sandlund JT, Pui CH, Roberts WM, Santana VM, Morris SW, Berard CW, Hutchison RE, Ribeiro RC, Mahmoud H, Crist WM. Clinico-pathologic features and treatment outcome of children with large- cell lymphoma and the t(2;5)(p23;q35). Blood 1994;84(8):2467-2471.
20. Reiter A, Schrappe M, Parwaresch R, Henze G, Muller-Weihrich S, Sauter S, Sykora KW, Ludwig WD, Gadner H, Riehm H. Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage - A report of the Berlin-Frankfurt-Münster Group. J Clin Oncol 1995;13(2):359-372.
21. Reiter A, Schrappe M, Tiemann M. Ludwig WD, Yakisan E, Zimmermann M, Mann G, Chott A, Ebell W, Klingebiel T, Graf N, Kremens B, Muller-Weihrich S, Pluss HJ, Zintl F, Henze G, Riehm H. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood 1999;94(10):3294-3306.
22. Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, Lutz P, Coze C, Perel Y, Raphael M, Terrier-Lacombe MJ. The Société Française d'Oncologie Pédiatrique LMB89 protocol: Highly effective multi-agent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001;97(11):3370-3379.
23. Anderson JR, Jenkin RD, Wilson JF, Kjeldsberg CR, Sposto R, Chilcote RR, Coccia PF, Exelby PR, Siegel S, Meadows AT, Hammond GD. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: A report of CCG-551 from the Children's Cancer Group [see comments]. J Clin Oncol 1993;11(6):1024-1032.
24. 2). N Engl J Med 1983;308(10):559-565.
25. Sposto R, Meadows AT, Chilcote RR, Steinherz PG, Kjeldsberg CR, Kadin ME, Krailo MD, Termuhlen AM, Morse M, Siegel SE. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol 2001;37:432-441.
26. Finlay JL, Anderson JR, Cecalupo AJ, Hutchinson RJ, Kadin ME, Kjeldsberg CR, Provisor AJ, Woods WG, Meadows AT. Disseminated nonlymphoblastic lymphoma of childhood: A Children's Cancer Group study, CCG-552. Med Pediatr Oncol 1994;23(6):453-463.
27. Cairo MS, Krailo MD, Morse M, Hutchinson RJ. Harris RE, Kjeldsberg CR, Kadin ME, Radel E, Steinherz LJ, Morris E, Finlay JL, Meadows AT. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ("Orange") in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: A Children's Cancer Group Report. Leukemia 2002;16(4):594-600.
28. Kobrinsky NL, Sposto R, Shah NR, Anderson JR, DeLaat C, Morse M, Warkentin P, Gilchrist GS, Cohen MD, Shina D, Meadows AT. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and L-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912. J Clin Oncol 2001;19(9):2390-2396.
29. Rappaport H. Tumors of the hematopoietic system. In: Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 1966. Fascicle 8.
30. The non-Hodgkin's lymphoma classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a Working Formulation for clinical usage. Cancer 1982;49:2112-2135.
31. Yakovlev AY. Parametric versus nonparametric methods for estimating cure rates based on censored survival data. Stat Med 1994;13:983-985.
32. Tsodikov A. A proportional hazards model taking account of longterm survivors. Biometrics 1998;54(4):1508-1516.
33. Lindsey JK. Parametric Statistical Inference. Oxford: Oxford Science Publications; 1996.
34. Cox DR, Oaks D. Analysis of Survival Data. London: Chapman and Hall; 1984.
35. Link MP, Donaldson SS, Berard CW, Shuster JJ, Murphy SB. Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med 1990;322(17):1169-1174.
36. Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G, Dorffel W, Zimmermann M, Mann G, Gadner H, Parwaresch R, Riehm H, Reiter A. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large-cell lymphoma: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood 2001;97(12):3699-3706.
37. Patte C, Philip T, Rodary C, Zucker JM, Behrendt H, Gentet JC, Lamagnere JP, Otten J, Dufillot D, Pein F. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 1991;9(1):123-132.
38. Patte C, Philip T, Rodary C. Bernard A, Zucker JM, Bernard JL, Robert A, Rialland X, Benz-Lemoine E, Demeocq F. Improved survival rate in children with stage III and IV B-cell non- Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol 1986;4(8):1219-1226.
39. Hutchison RE, Berard CW, Shuster JJ, Link MP, Pick TE, Murphy SB. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: A Pediatric Oncology Group study. J Clin Oncol 1995;13(8):2023-2032.